Dr Sara Hanning


Sara completed her PhD in pharmacy at the University of Otago in 2013 before taking a position as a research associate in paediatric pharmaceutics at UCL School of Pharmacy, UK. Sara returned to NZ in January 2017 and joined the University of Auckland as a Lecturer in Clinical Pharmacy Practice. Her research interests remain at the interface between pharmaceutics and clinical practice, with a focus on the development of safe and effective dosage forms for children.

Research | Current

Research interests

  • Paediatric formulation development
  • Novel drug delivery systems
  • Extemporaneous compounding
  • Acceptability of "child-friendly" dosage forms
  • Availability and accessibility of paediatric medicines


Pharmacy 213

  • Course Director
  • Module leader, Infectious Diseases

Pharmacy 412

  • Module leader, Paediatrics

Selected publications and creative works (Research Outputs)

  • Hanning, S. M., Medlicott, N. J., & Oliphant, E. A. (2019). Clinical Pharmacy Considerations in Special Population: Pediatrics. In Z. Babar (Ed.) Encyclopedia of Pharmacy Practice and Clinical Pharmacy (pp. 815-830). Academic Press. 10.1016/B978-0-12-812735-3.00574-4
    URL: http://hdl.handle.net/2292/47798
    Other University of Auckland co-authors: Elizabeth Oliphant
  • Hanning, S. M., Orlu Gul, M., Toni, I., Neubert, A., Tuleu, C., & CloSed Consortium (2017). A mini-review of non-parenteral clonidine preparations for paediatric sedation. Journal of Pharmacy and Pharmacology, 69 (4), 398-405. 10.1111/jphp.12662
  • Hanning, S. M., Orlu Gul, M., Winslade, J., Baarslag, M. A., Neubert, A., Tuleu, C., & CloSed Consortium (2016). Quality and clinical supply considerations of Paediatric Investigation Plans for IV preparations - A case study with the FP7 CloSed project. International Journal of Pharmaceutics, 511 (2), 1158-1162. 10.1016/j.ijpharm.2016.04.051

Contact details

Primary office location

M&HS BUILDING 505 - Bldg 505
Level 3, Room 366
New Zealand